News

The first tier of Signature’s prenatal service, the enhanced PrenatalChip targets over 100 discrete chromosomal regions, the gain or loss of which results in a genetic disorder, while

In recent years, the US hospital market has received this product through an exclusive distribution arrangement with Abbott. OraSure and Abbott have previously entered into an agreement under

The thymalfasin treatment group did not achieve statistical significance for the primary endpoint of sustained virological response (SVR) as assessed in the primary analysis population, ie, the intent-to-treat

A key aim of the collaboration is to investigate if genetic variants Celera has identified can predict how patients may respond to treatment. The identification of treatment response

Cardo Medical’s innovative total knee system is the flagship product within its Align 360 platform, which has already received the FDA clearance for its uni-compartmental and patello-femoral systems.

Included among the purchasers of the shares is Peter Friedli, the company’s chairman, individually. The board of directors of the company, including all of the company’s independent directors,

According to the company, chromatin immunoprecipitation (ChIP-chip) HD2 arrays now provide more than a five-fold increase in probe density per array, which allows for increasing the coverage of

Ferring has been notified recently that the mutual recognition process for European member states has been positively concluded for the Zomacton 10mg formulation and the Antares’s needle-free injection

Carbidopa with levodopa extended release is indicated for the treatment of Parkinson’s disease and syndrome. These generic extended release versions of carbidopa with levodopa are bio-equivalent to Sinemet